4596.T
Kubota Pharmaceutical Holdings Co.,Ltd.
グロース · 医薬品 · 医薬品 · JP
JPY 64.00
−1.54%Year over year
Reported trailing growth
- Revenue
- -22.2%
- EBITDA
- —
- EBIT
- +30.6%
- EPS
- +52.3%
- Free cash flow
- +52.5%
- Operating cash flow
- +51.4%
Forward estimates
Based on analyst estimates
- Revenue
- -66.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +37.9%
- EBITDA
- —
- EBIT
- +30.6%
- Net income
- +49.3%
- EPS
- +55.2%
- Free cash flow
- +52.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026